tiprankstipranks
Oncimmune Holdings PLC (DE:OCY)
STUTTGART:OCY

Oncimmune Holdings (OCY) Financial Statements

0 Followers

Oncimmune Holdings Financial Overview

Oncimmune Holdings's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Oncimmune Holdings is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
May 22Nov 21May 21Nov 20May 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 2.53M£ 2.96M£ 8.63M£ 3.28M£ 4.24M
Total Assets£ 17.26M£ 18.18M£ 24.28M£ 9.59M£ 10.31M
Total Debt£ 10.69M£ 8.36M£ 9.47M£ 10.51M£ 8.28M
Net Debt£ 8.16M£ 5.39M£ 837.00K£ 7.22M£ 4.04M
Total Liabilities£ 19.98M£ 16.95M£ 19.05M£ 12.02M£ 10.51M
Stockholders Equity£ -2.73M£ 1.23M£ 5.23M£ -2.43M£ -194.00K
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Oncimmune Holdings Earnings and Revenue History

Oncimmune Holdings Debt to Assets

Oncimmune Holdings Cash Flow

Oncimmune Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis